RALEIGH, N.C., Sept. 23 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, will present at the 11th Registries and Post Approval Studies Congress on September 23-25 in Washington, DC. Kathleen Kushner, MPH, RN, the Strategic Director of Late Phase Services at PRA, will discuss the optimization of the interim and final analysis processes. Kushner’s presentation will utilize evidence from applicable case studies to provide analytical techniques for managing post-approval study results.
PRA provides extensive Phase IV Post-Marketing services to pharmaceutical and biotech companies. The company has executed more than 150 Late Phase studies in 23 countries, recruiting over 126,000 patients in nearly 12,000 sites.
About PRA International
PRA International is a global Clinical Research Organization providing services through all phases of clinical development. We specialize in Oncology, CNS, respiratory/allergy diseases, cardiovascular and infectious diseases. PRA has supported over 2,100 clinical trials in more than 60 countries on six continents through our global offices. PRA’s therapeutic expertise, global reach, and project experience with local knowledge enable our project teams to deliver consistent and on time performance for our clients. PRA’s Late Phase Services group supports global and regional post- approval studies with management in North America and Europe.
To learn more about PRA International, please visit http://www.prainternational.com, email endpoints@praintl.com or call our Global Headquarters at +1 (919) 786-8200.
CONTACT: Zishan Haroon, MD, PhD of PRA International, Inc.,
+1-919-786-8308; or Tim Grace of Financial Relations Board,
+1-312-640-6667, for PRA International
Web site: http://www.prainternational.com/
